Nimotop

In the US, Nimotop (nimodipine systemic) is a member of the drug class calcium channel blocking agents and is used to treat Ischemic Stroke, Migraine Prevention and Subarachnoid Hemorrhage.

US matches:

• Nimotop

UK matches:

• Nimotop 0.02% Solution for Infusion (SPC)
• Nimotop 30mg Tablets (SPC)

Ingredient matches for Nimotop

Nimesulide

Nimesulide is reported as an ingredient of Nimotop in the following countries:

• Latvia

Nimodipine

Nimodipine is reported as an ingredient of Nimotop in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Bosnia & Herzegowina


• Brazil


• Canada


• Chile


• China


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• El Salvador


• Estonia


• Finland


• France


• Georgia


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Israel


• Italy


• Luxembourg


• Malaysia


• Malta


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Turkey


• United Kingdom


• United States


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.